About
HeartSine Technologies, based in Belfast, Northern Ireland, is a medical technology company that specializes in Automated External Defibrillators (AEDs). Founded in 1998 as a spinout from the University of Ulster, the company has a rich history in defibrillator development, tracing back to the creation of the world’s first mobile defibrillator in the 1960s. HeartSine is now part of Stryker Corporation’s Emergency Care division. The company’s primary products are the Samaritan PAD series of AEDs, designed for public access use. These devices are compact, lightweight, and user-friendly, making them suitable for both lay rescuers and medical professionals. They feature advanced technology like the SCOPE™ biphasic waveform, which enhances their effectiveness in treating sudden cardiac arrest. HeartSine is committed to providing affordable, high-quality defibrillators, recognizing that most cardiac arrests occur outside of medical settings. HeartSine operates advanced facilities in Belfast, focusing on research, development, and manufacturing. Their products are distributed globally through Stryker’s network, supporting communities and organizations in responding to cardiac emergencies effectively.
Technologies
Keywords
Company Information
-
Employees 41
-
Founded 1997
-
Annual Revenue $9574000
-
Total Funding $3130720
Location
121 Friends Ln, Newtown, Pennsylvania, United States, 18940
